Tamoxifen prevents breast cancer in women older than 60 years and in younger women with equally high risk because of breast disease and reproductive and family history, but there is no current evidence for or against long-term survival or overall health benefits.(Grade of recommendation A: randomized controlled trials [RCTs]) a 49% reduction in 5-year incidence of invasive and noninvasive breast cancer but increased risk for endometrial cancer, pulmonary emboli, deep vein thrombosis, and cataracts. The long-term benefits and overall health effects of tamoxifen for primary prevention of breast cancer remain unclear; the ongoing International Breast Cancer Intervention Study trial is designed to address this question
Background Four previously published randomised clinical trials have shown that tamoxifen can reduce...
Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamox...
Epidemiological, experimental, and clinical data strongly support the possibility that breast cancer...
Background Three clinical trials on the use of tamoxifen to prevent breast cancer have reported mixe...
BACKGROUND: Three clinical trials on the use of tamoxifen to prevent breast cancer have reported mix...
Background: Three clinical trials on the use of tamoxifen to prevent breast cancer have reported mix...
Background: Four previously published randomised clinical trials have shown that tamoxifen can reduc...
Background: For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamo...
Background: For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamo...
Tamoxifen has been used clinically for more than 30 years (1). The compound is a nonsteroidal anties...
strated that tamoxifen treatment produced a 49 % reduction in the risk of invasive breast cancer amo...
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial a...
Background: Initial findings of the Italian Randomized Tamoxifen Prevention Trial found no reduction...
BACKGROUND: For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamo...
18Background Initial findings of the Italian Randomized Tamoxifen Prevention Trial found no reductio...
Background Four previously published randomised clinical trials have shown that tamoxifen can reduce...
Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamox...
Epidemiological, experimental, and clinical data strongly support the possibility that breast cancer...
Background Three clinical trials on the use of tamoxifen to prevent breast cancer have reported mixe...
BACKGROUND: Three clinical trials on the use of tamoxifen to prevent breast cancer have reported mix...
Background: Three clinical trials on the use of tamoxifen to prevent breast cancer have reported mix...
Background: Four previously published randomised clinical trials have shown that tamoxifen can reduc...
Background: For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamo...
Background: For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamo...
Tamoxifen has been used clinically for more than 30 years (1). The compound is a nonsteroidal anties...
strated that tamoxifen treatment produced a 49 % reduction in the risk of invasive breast cancer amo...
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial a...
Background: Initial findings of the Italian Randomized Tamoxifen Prevention Trial found no reduction...
BACKGROUND: For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamo...
18Background Initial findings of the Italian Randomized Tamoxifen Prevention Trial found no reductio...
Background Four previously published randomised clinical trials have shown that tamoxifen can reduce...
Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamox...
Epidemiological, experimental, and clinical data strongly support the possibility that breast cancer...